P—Reference library
Peptides
Regulatory status and a summary of what is reported and claimed.
29 of 29 peptides
| Name | Type | Compounding | Categories | Evidence level | Ev. vs. Hype | Momentum | WADA | Reviewed | + |
|---|---|---|---|---|---|---|---|---|---|
| AHK-Cu | Cosmetic / Supplement | Unclear / not listed | Skin & cosmetic | In vitro / theoretical | Evidence Hype | Watch | Verify | 2026-10-30 | |
| AHK-Cu + GHK-Cu Blend Hair stack | Research Only | Not allowed (blends excluded) | Skin & cosmetic | In vitro / theoretical | Evidence Hype | Watch | Verify | 2026-10-30 | |
| BPC-157 Body Protection Compound | Research Only | Off Category 2, review pending | Healing & repair, GI | Animal studies mostly | Evidence Hype | Rising | Prohibited | 2026-10-30 | |
| BPC-157 + TB-500 Blend Wolverine blend · Wolverine | Research Only | Not allowed (blends excluded) | Healing & repair | Animal studies mostly | Evidence Hype | Watch | Prohibited | 2026-10-30 | |
| Cagrilintide | Investigational | Trial use only | Metabolic / GLP-1 | Human trials ongoing | Evidence Hype | Rising | Prohibited | 2026-10-30 | |
| CagriSema Cagrilintide + semaglutide | Investigational | Not allowed (blends excluded) | Metabolic / GLP-1 | Human trials ongoing | Evidence Hype | Watch | Prohibited | 2026-10-30 | |
| CJC-1295 | Research Only | Not cleared (advisory panel rejected) | Growth hormone axis | Small/early human studies | Evidence Hype | Watch | Prohibited | 2026-10-30 | |
| CJC-1295 + Ipamorelin Blend CJC/Ipa · CJC-Ipamorelin | Research Only | Not allowed (blends excluded) | Growth hormone axis | Small/early human studies | Evidence Hype | Watch | Prohibited | 2026-10-30 | |
| Elamipretide SS-31 | FDA Approved | Approved product (not applicable) | Longevity & mitochondrial | Small/early human studies | Evidence Hype | Watch | Verify | 2026-10-30 | |
| Epitalon Epithalon | Research Only | Off Category 2, review pending | Longevity & mitochondrial | Small/early human studies | Evidence Hype | Watch | Verify | 2026-10-30 | |
| GHK-Cu Copper peptide | Cosmetic / Supplement | Off Category 2, review pending | Skin & cosmetic, Longevity & mitochondrial | Small/early human studies | Evidence Hype | Rising | Verify | 2026-10-30 | |
| GLOW Blend GLOW blend | Research Only | Not allowed (blends excluded) | Skin & cosmetic, Healing & repair | Animal studies mostly | Evidence Hype | Watch | Prohibited | 2026-10-30 | |
| Ipamorelin | Research Only | Not cleared (advisory panel rejected) | Growth hormone axis | Small/early human studies | Evidence Hype | Watch | Prohibited | 2026-10-30 | |
| KLOW Blend KLOW blend | Research Only | Not allowed (blends excluded) | Healing & repair, GI, Skin & cosmetic | Animal studies mostly | Evidence Hype | Watch | Prohibited | 2026-10-30 | |
| KPV | Research Only | Off Category 2, review pending | GI, Healing & repair | Animal studies mostly | Evidence Hype | Rising | Verify | 2026-10-30 | |
| LL-37 | Investigational | Off Category 2, review pending | Immune | Small/early human studies | Evidence Hype | Watch | Verify | 2026-10-30 | |
| MOTS-c | Research Only | Off Category 2, review pending | Longevity & mitochondrial | Animal studies mostly | Evidence Hype | Rising | Prohibited | 2026-10-30 | |
| NAD+ Nicotinamide adenine dinucleotide | Research Only | Compounded by pharmacies (verify) | Longevity & mitochondrial | Small/early human studies | Evidence Hype | Rising | Verify | 2026-10-30 | |
| Pinealon | Research Only | Unclear / not listed | Longevity & mitochondrial, Cognitive & mood | Animal studies mostly | Evidence Hype | Watch | Verify | 2026-10-30 | |
| Retatrutide LY3437943 | Investigational | Trial use only | Metabolic / GLP-1 | Human trials ongoing | Evidence Hype | Rising | Prohibited | 2026-10-30 | |
| Selank | Approved Outside US | Off Category 2, review pending | Cognitive & mood | Small/early human studies | Evidence Hype | Watch | Verify | 2026-10-30 | |
| Semaglutide Ozempic · Wegovy · Rybelsus | FDA Approved | Approved product (not applicable) | Metabolic / GLP-1 | Human RCTs (approved use) | Evidence Hype | Steady | Not prohibited | 2026-10-30 | |
| Semax | Approved Outside US | Off Category 2, review pending | Cognitive & mood | Small/early human studies | Evidence Hype | Watch | Verify | 2026-10-30 | |
| Semax + Selank Blend Nootropic stack · Focus & calm stack | Research Only | Not allowed (blends excluded) | Cognitive & mood | Small/early human studies | Evidence Hype | Watch | Verify | 2026-10-30 | |
| TB-500 Thymosin Beta-4 fragment | Research Only | Off Category 2, review pending | Healing & repair | Animal studies mostly | Evidence Hype | Watch | Prohibited | 2026-10-30 | |
| Tesamorelin Egrifta | FDA Approved | Approved product (not applicable) | Growth hormone axis | Human RCTs (approved use) | Evidence Hype | Steady | Prohibited | 2026-10-30 | |
| Tesamorelin + Ipamorelin Blend Tesa/Ipa | Research Only | Not allowed (blends excluded) | Growth hormone axis | Small/early human studies | Evidence Hype | Watch | Prohibited | 2026-10-30 | |
| Thymosin Alpha-1 | Approved Outside US | Not cleared (advisory panel rejected) | Immune | Human RCTs (approved use) | Evidence Hype | Watch | Verify | 2026-10-30 | |
| Tirzepatide Mounjaro · Zepbound | FDA Approved | Approved product (not applicable) | Metabolic / GLP-1 | Human RCTs (approved use) | Evidence Hype | Rising | Not prohibited | 2026-10-30 |